Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA
J Virol. 2018 Apr 13;92(9). doi: 10.1128/JVI.00053-18. Print 2018 May 1.
Type I interferons (IFNs) induce expression of more than 300 cellular genes that provide protection against viruses and other pathogens. For survival, viruses evolved defenses to prevent the IFN response or counteract the IFN-induced antiviral state. However, because viruses and cells coevolved, the dynamic relationship between virus and host is difficult to discern. In the present study, we demonstrated that vaccinia virus with a large deletion near the left end of the genome had a diminished ability to replicate in cells that had been pretreated with beta interferon (IFN-β), suggesting that one or more of the missing 17 open reading frames (ORFs) encode an antagonist of the IFN-induced antiviral state. By systematically deleting groups of ORFs and then individual ORFs, the C9L gene was shown to be required for IFN resistance. Replication of the C9L deletion mutant (vΔC9) was impaired in human cells that had been pretreated with IFN-β. Expression of viral early genes occurred, but subsequent events, including genome uncoating, genome replication, and postreplicative gene expression, were inhibited. Expression of the C9 protein occurred prior to genome replication, consistent with an early role in counteracting the IFN-induced antiviral state. C9 contains six ankyrin repeat motifs and a near C-terminal F-box. Mass spectrometry and immunoblotting identified host proteins that copurified with a functional epitope-tagged C9. The most abundant proteins were components of the SCF (CUL1, SKP1, F-box) and signalosome/deneddylation complexes, which interact with each other, suggesting a possible role in proteolysis of one or more interferon-induced proteins. Poxviruses comprise a family of large DNA viruses that replicate in the cytoplasm of vertebrate and insect hosts and cause human and zoonotic diseases. In most cases the primary infection is moderated by innate immune defenses. Vertebrates, including fish, amphibians, reptiles, birds, and mammals, all produce type I interferon homologs. In humans, interferon stimulates the synthesis of more than 300 proteins thought to have roles in host defense. Conversely, viruses have evolved means to thwart the host defenses. We are attempting to deconstruct the established virus-host relationship in order to better understand the molecular mechanisms involved. In the present study, we identified a vaccinia virus gene that prevents interferon-mediated inhibition of very early stages of viral replication and is conserved in orthopoxviruses. The viral protein was shown to interact with host proteins involved in proteolysis, suggesting that vaccinia virus may subvert the cellular apparatus for its own defense.
I 型干扰素 (IFNs) 诱导超过 300 种细胞基因的表达,为机体提供抵抗病毒和其他病原体的保护。为了生存,病毒进化出了防御机制来阻止 IFN 反应或抵消 IFN 诱导的抗病毒状态。然而,由于病毒和细胞共同进化,病毒与宿主之间的动态关系难以辨别。在本研究中,我们证明了基因组左侧附近有大片段缺失的痘苗病毒在经β干扰素 (IFN-β) 预处理的细胞中复制能力减弱,这表明缺失的 17 个开放阅读框 (ORFs) 之一或多个缺失 ORF 编码了一种 IFN 诱导的抗病毒状态的拮抗剂。通过系统地删除一组 ORFs 然后逐个删除 ORFs,发现 C9L 基因是 IFN 抗性所必需的。预处理过 IFN-β 的人细胞中,C9L 缺失突变体 (vΔC9) 的复制受到了损害。病毒早期基因的表达发生了,但随后的事件,包括基因组脱壳、基因组复制和复制后基因表达,都受到了抑制。C9 蛋白的表达发生在基因组复制之前,这与它在拮抗 IFN 诱导的抗病毒状态中的早期作用一致。C9 包含六个锚蛋白重复基序和近 C 端 F-box。质谱和免疫印迹鉴定了与功能表位标记的 C9 共纯化的宿主蛋白。最丰富的蛋白质是 SCF (CUL1、SKP1、F-box) 和信号体/去泛素化复合物的组成部分,它们相互作用,这表明它们可能在一种或多种 IFN 诱导蛋白的蛋白水解中发挥作用。痘病毒属于一组在脊椎动物和昆虫宿主的细胞质中复制的大型 DNA 病毒,会引起人类和人畜共患疾病。在大多数情况下,原发性感染受到先天免疫防御的调节。包括鱼类、两栖动物、爬行动物、鸟类和哺乳动物在内的脊椎动物都产生 I 型干扰素同源物。在人类中,干扰素刺激超过 300 种蛋白质的合成,这些蛋白质被认为在宿主防御中起作用。相反,病毒已经进化出了挫败宿主防御的手段。我们正试图解构已建立的病毒-宿主关系,以便更好地理解所涉及的分子机制。在本研究中,我们鉴定了一种痘苗病毒基因,该基因可阻止干扰素介导的病毒复制的极早期阶段的抑制作用,并且在正痘病毒中保守。该病毒蛋白被证明与参与蛋白水解的宿主蛋白相互作用,这表明痘病毒可能会颠覆细胞的防御机制来保护自己。